PacBio News Doesn't Seem /That/ Bad? Does It?
PacBio released preliminary Q1 revenue and then the stock price dropped ~50%. Market cap currently stands at ~$375M:
They’ve also said they are going to reduce burn with one analyst quoted on GenomeWeb saying "PacBio commented to us that it may reduce its headcount by triple digits to generate these expense reductions.". Another commented on influencing …